UK Government Launches Volunteer Strategy Consultation

Health Secretary Alan Johnson today launched a six-month consultation to improve support for volunteers in the NHS, social care and third sector, and to encourage more volunteering opportunities.The consultation, 'Towards a strategy to support volunteering in health and social care' will lead to a national volunteering strategy next year.

Walking At A Steady Pace Is The Most Effective Way To Reduce Blood Pressure

If walking seems too simple to be an effective fitness method, think again: taking a stroll for 30 minutes is the easiest way to lower blood pressure, according to the Department of Sport Science, Tourism and Leisure, Canterbury Christ Church University.

New Standards For Treating Substance Use Disorders Ready For Use

New clinician-level performance measures for treating patients with known substance use disorders were approved at the AMA-convened Physician Consortium for Performance Improvement (Consortium) meeting in the nation's capital. The new measures are the first Consortium measures in this topic area, and are ready for use by physicians and other health care providers.

Further Clinical Testing Of BZL101 In Advanced Breast Cancer Demonstrates Favorable Efficacy And Toxicity Profiles

Bionovo Inc. (Nasdaq: BNVI) announced results from a second ongoing clinical trial of BZL101, an oral drug candidate, in patients with refractory, metastatic breast cancer.

Major Health Survey Underway In Southeastern Pennsylvania - Residents To Play Important Role In Improving Area Health

Over the next few months, the Community Health Data Base (CHDB) will be conducting the 2008 Southeastern Pennsylvania (SEPA) Household Health Survey, a major telephone survey to examine the health and health care experiences of area residents. The CHDB, a program of Philadelphia Health Management Corporation (PHMC) will contact approximately 13, 000 households throughout the region.

Leading Immunologists Convene In Boston

Over a thousand scientists and clinicians will convene to present new advances in understanding and treating immune-mediated diseases at FOCIS 2008, the 8th annual meeting of the Federation of Clinical Immunology Societies (FOCIS), June 5-9 at the Boston Marriott Copley Place.

Exelixis Reports Phase 1 And Phase 2 Data For XL647 At ASCO

Exelixis, Inc. (Nasdaq: EXEL) reported data from three clinical trials of XL647, a novel small molecule inhibitor of EGFR, HER2, and VEGFR2, at the 44th Annual Meeting of the American Society of Clinical Oncology (ASCO).

AMA Calls On Rudd Govt To Change Gp Super Clinics Policy Framework, Australia

The National Conference of the Austalian Medical Association called on the Federal Government to work with the peak medical body to improve access to GP services for all Australians. AMA President, Dr Rosanna Capolingua, said that funding cuts to General Practice in the recent Federal Budget were disappointing and undermined the Government's commitment to stronger primary health care services.

International Union Against Tuberculosis And Lung Disease Calls For Urgent Action To Curb Tobacco Marketing To Youth

The International Union Against Tuberculosis and LungDisease (The Union), an international organisation established in 1920 to fight TB andpromote lung health worldwide, today celebrates World No Tobacco Day by calling ongovernments to enact policies that protect young people: bans on tobacco promotion, increases in taxes, and graphic picture warning.

Cediranib Recentin, AZD2171 - Supportive Data From The National Cancer Institute NCI Evaluate Clinical Activity Across A Range Of Tumour Types

New data being presented at ASCO add to the evidence base supporting the potential utility of cediranib (RECENTINTM, AZD2171) across a wide range of tumour types.